Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kummer

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Parasites & Vectors|April 24, 2025
Evaluation of the 2022 West Nile virus forecasting challenge, USARyan D Harp, Karen M Holcomb, Renata Retkute, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Nature Communications|July 26, 2024
Title evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Parasites & Vectors|April 24, 2025
Evaluation of the 2022 West Nile virus forecasting challenge, USARyan D Harp, Karen M Holcomb, Renata Retkute, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Nature Communications|July 26, 2024
Title evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Pageof 6